Outpatient Oncology Infusion Global Market Insights: Growth Drivers, Size & Forecasts to 2029

Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.

What Is the Forecasted Market Growth Rate of the Outpatient Oncology Infusion Industry?
The size of the outpatient oncology infusion market has been expanding robustly over the past few years. Its growth is predicted to scale from $12.99 billion in 2024 to $14.02 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.9%. Factors such as an increase in cancer cases, the growth of outpatient centres, a preference for homely healthcare environments, improved insurance coverage, a shift from inpatient to outpatient care, and increasing survival rates have been major contributors to the historic period's growth.

How Will the Outpatient Oncology Infusion Market Size Evolve From 2025 to 2029?
The market size of outpatient oncology infusion is anticipated to undergo robust expansion in the forthcoming years. The market is projected to reach $18.81 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. The projected increase during the forecast period is generally ascribed to factors such as an ageing global population, surging demand for personalised medicine, escalating usage of biosimilars, emphasis on cost management, value-driven reimbursement models, and labour shortages. Key trends predicted during the forecast period encompass advancements in infusion apparatus, inclusion of telehealth services, technology-aided remote patient monitoring, progress in personalised medication, and breakthroughs in targeted treatments.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report

What Are the Main Growth Drivers in the Outpatient Oncology Infusion Market Today?
The escalation in the incidence of cancer is anticipated to stimulate the progression of the outpatient oncology infusion market in the future. Cancer, categorized as a complex disease, is characterized by the unregulated growth of abnormal cells that can infiltrate nearby tissues and metastasize to different parts of the body. The elderly are more prone to cancer, which explains its spread globally. Outpatient oncology infusion is a method used to give cancer treatments like chemotherapy, immunotherapy, or targeted therapy in a clinical environment without the need for hospitalization, enabling patients to carry on with their day-to-day lives. For example, Macmillan Cancer Support, a UK-based charity that lends practical, emotional, and financial aid to people affected by cancer, predicts that by April 2024, the current number of UK residents living with cancer, which is 3 million, will escalade to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Thus, the escalating incidence of cancer is fueling the progression of the outpatient oncology infusion market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp

Which Outpatient Oncology Infusion Market Segment Is Expected to Lead Through 2029?
The outpatient oncology infusion market covered in this report is segmented -

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors
2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy
3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers
4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings

Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps
2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets
3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas
4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

Which Market Trends Are Expected to Dominate Outpatient Oncology Infusion Industry Growth?
Leading businesses in the outpatient oncology infusion market are prioritizing the development of innovative tools such as syringe infusion pumps to improve infusion precision, heighten patient safety, and simplify the process of medication delivery employing enhanced software and systems to reduce dosage errors. A syringe infusion pump, also identified as a syringe driver, is a mechanically operated device engineered to regulate the flow of fluids accurately by physically manipulating the plunger of a syringe. Take for example, in August 2022, Baxter International Inc., an American healthcare firm renowned for its expertise in surgical and intravenous infusion technologies, was given approval by the U.S. Food and Drug Administration (FDA) for its Novum IQ Syringe Infusion Pump (SYR), which is combined with Dose IQ Safety Software. This system leverages Baxter's sophisticated, internet-based Dose IQ platform that possesses a modifiable drug library and error reduction feature for dosing, intended to support clinicians and healthcare establishments by providing up-to-date medication data. The system, specifically created for outpatient healthcare facilities, including outpatient oncology infusion locations, administers precise, programmable infusions of therapeutic drugs across a wide range of clinical care environments.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25861&type=smp

Which Companies Hold the Largest Market Share in the Outpatient Oncology Infusion Sector?
Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

Where Is the Outpatient Oncology Infusion Market Experiencing the Highest Growth?
North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.